Top Markets
Coin of the day
Lumos Diagnostics Holdings Limited Lumos Diagnostics Holdings Limited

Lumos Diagnostics Holdings Limited

LDX
Classifica tra le azioni #23727
Lumos Diagnostics Holdings Limited develops, manufactures, and commercializes... Lumos Diagnostics Holdings Limited develops, manufactures, and commercializes point-of-care diagnostic products for diagnosis and management of infectious diseases in the United States. The company’s products include FebriDx, a point-of-care diagnostic test for detecting and differentiating viral and bacterial respiratory infections; and ViraDx, a three-in-one point-of-care test for influenza A, influenza B, and COVID-19. It also provides assay development and manufacturing services for point-of-care tests and proprietary digital reader platforms. Lumos Diagnostics Holdings Limited was incorporated in 2018 and is based in Carlsbad, California.
Prezzo delle azioni
$0.0740549
Ultima sincronizzazione: 2026-08-21
Capitalizzazione di mercato
$69.97M
Variazione (1 giorno)
0.00%
Variazione (1 anno)
21.33%
Paese
AU
Scambia Lumos Diagnostics Holdings Limited (LDX)

Categoria

Rapporto P/B per Lumos Diagnostics Holdings Limited (LDX)
Rapporto P/B al 2026 TTM: 0
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Lumos Diagnostics Holdings Limited, il rapporto P/B attuale (TTM) è 0. Alla fine del 2026, era pari a 0.
Storico del rapporto P/B per Lumos Diagnostics Holdings Limited da 2026 a 2026
Rapporto P/B alla fine di ogni anno
Anno Rapporto P/B Cambia
Non abbastanza dati per le date fornite.
Rapporto P/B per aziende simili o concorrenti